These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 21320123)

  • 21. Increased natural killer cell subsets with inhibitory cytokines and inhibitory surface receptors in patients with recurrent miscarriage and decreased or normal subsets in kidney transplant recipients late post-transplant.
    Zhu L; Aly M; Wang H; Karakizlis H; Weimer R; Morath C; Kuon RJ; Toth B; Ekpoom N; Opelz G; Daniel V
    Clin Exp Immunol; 2018 Aug; 193(2):241-254. PubMed ID: 29679490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human CD56bright and CD56dim natural killer cell subsets respond differentially to direct stimulation with Mycobacterium bovis bacillus Calmette-Guérin.
    Batoni G; Esin S; Favilli F; Pardini M; Bottai D; Maisetta G; Florio W; Campa M
    Scand J Immunol; 2005 Dec; 62(6):498-506. PubMed ID: 16316416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human liver-resident CD56(bright)/CD16(neg) NK cells are retained within hepatic sinusoids via the engagement of CCR5 and CXCR6 pathways.
    Hudspeth K; Donadon M; Cimino M; Pontarini E; Tentorio P; Preti M; Hong M; Bertoletti A; Bicciato S; Invernizzi P; Lugli E; Torzilli G; Gershwin ME; Mavilio D
    J Autoimmun; 2016 Jan; 66():40-50. PubMed ID: 26330348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ex vivo generated natural killer cells acquire typical natural killer receptors and display a cytotoxic gene expression profile similar to peripheral blood natural killer cells.
    Lehmann D; Spanholtz J; Osl M; Tordoir M; Lipnik K; Bilban M; Schlechta B; Dolstra H; Hofer E
    Stem Cells Dev; 2012 Nov; 21(16):2926-38. PubMed ID: 22571679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic.
    Ferlazzo G; Thomas D; Lin SL; Goodman K; Morandi B; Muller WA; Moretta A; Münz C
    J Immunol; 2004 Feb; 172(3):1455-62. PubMed ID: 14734722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Human peripheral blood CD56+ natural killer cell subsets and their phenotypic and biological properties].
    Wu CY; Liu J; Yang BY; Roedere M
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):169-72. PubMed ID: 16875598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Programmed cell death 1-expressing CD56-negative natural killer (NK) cell expansion is a hallmark of chronic NK cell activation during dasatinib treatment.
    Ishiyama KI; Kitawaki T; Otsuka Y; Takaori-Kondo A; Kadowaki N
    Cancer Sci; 2021 Feb; 112(2):523-536. PubMed ID: 33064914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-15 alters expression and function of the chemokine receptor CX3CR1 in human NK cells.
    Sechler JM; Barlic J; Grivel JC; Murphy PM
    Cell Immunol; 2004 Aug; 230(2):99-108. PubMed ID: 15598425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Late Development of FcεRγ
    Muccio L; Falco M; Bertaina A; Locatelli F; Frassoni F; Sivori S; Moretta L; Moretta A; Della Chiesa M
    Front Immunol; 2018; 9():1050. PubMed ID: 29868012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The CD6 scavenger receptor is differentially expressed on a CD56 natural killer cell subpopulation and contributes to natural killer-derived cytokine and chemokine secretion.
    Braun M; Müller B; ter Meer D; Raffegerst S; Simm B; Wilde S; Spranger S; Ellwart J; Mosetter B; Umansky L; Lerchl T; Schendel DJ; Falk CS
    J Innate Immun; 2011; 3(4):420-34. PubMed ID: 21178331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD56bright human NK cells differentiate into CD56dim cells: role of contact with peripheral fibroblasts.
    Chan A; Hong DL; Atzberger A; Kollnberger S; Filer AD; Buckley CD; McMichael A; Enver T; Bowness P
    J Immunol; 2007 Jul; 179(1):89-94. PubMed ID: 17579025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A New Hope for CD56
    Forconi CS; Oduor CI; Oluoch PO; Ong'echa JM; Münz C; Bailey JA; Moormann AM
    Front Cell Infect Microbiol; 2020; 10():162. PubMed ID: 32373555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human natural killer cell subsets and acute exercise: a brief review.
    Timmons BW; Cieslak T
    Exerc Immunol Rev; 2008; 14():8-23. PubMed ID: 19203081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imbalance between CD56+bright and CD56+dim natural killer cell subsets in the liver of patients with recurrent hepatitis C after liver transplantation.
    Yamagiwa S; Sato Y; Ichida T; Setsu T; Tominaga K; Kamimura H; Tsuchiya A; Takamura M; Matsuda Y; Aoyagi Y
    Biomed Res; 2014; 35(3):177-84. PubMed ID: 24942856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functionally distinct subsets of human NK cells and monocyte/DC-like cells identified by coexpression of CD56, CD7, and CD4.
    Milush JM; Long BR; Snyder-Cappione JE; Cappione AJ; York VA; Ndhlovu LC; Lanier LL; Michaëlsson J; Nixon DF
    Blood; 2009 Nov; 114(23):4823-31. PubMed ID: 19805616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipopolysaccharide stimulates the proliferation of human CD56+CD3- NK cells: a regulatory role of monocytes and IL-10.
    Goodier MR; Londei M
    J Immunol; 2000 Jul; 165(1):139-47. PubMed ID: 10861046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Active but not inactive granulomatosis with polyangiitis is associated with decreased and phenotypically and functionally altered CD56(dim) natural killer cells.
    Merkt W; Claus M; Blank N; Hundemer M; Cerwenka A; Lorenz HM; Watzl C
    Arthritis Res Ther; 2016 Sep; 18(1):204. PubMed ID: 27624647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human CD56bright NK Cells: An Update.
    Michel T; Poli A; Cuapio A; Briquemont B; Iserentant G; Ollert M; Zimmer J
    J Immunol; 2016 Apr; 196(7):2923-31. PubMed ID: 26994304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective depletion of CD56(dim) NK cell subsets and maintenance of CD56(bright) NK cells in treatment-naive HIV-1-seropositive individuals.
    Tarazona R; Casado JG; Delarosa O; Torre-Cisneros J; Villanueva JL; Sanchez B; Galiani MD; Gonzalez R; Solana R; Peña J
    J Clin Immunol; 2002 May; 22(3):176-83. PubMed ID: 12078859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene and protein characteristics reflect functional diversity of CD56dim and CD56bright NK cells.
    Wendt K; Wilk E; Buyny S; Buer J; Schmidt RE; Jacobs R
    J Leukoc Biol; 2006 Dec; 80(6):1529-41. PubMed ID: 16966385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.